Tradestie Institutional Equity Comparison Engine

AUBN vs CBAN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CBAN Overall Edge

CBAN Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Colony Bankcorp Inc. (CBAN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AUBN trades at 9.2x Forward P/E with 33.5% operating margin (+4.4% YoY revenue) versus CBAN at 8.0x Forward P/E and 33.4% operating margin (+26.0% YoY). In options structure, AUBN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CBAN sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CBAN
AUBN 9.2x vs CBAN 8.0x Fwd P/E
Growth & Margin Winner CBAN
Op Margin 33.5% vs 33.4% ยท YoY +4.4% vs +26.0%
Momentum & Technical Winner CBAN
1Y -10.9% vs +18.9% ยท 52W Pos 44% vs 49%
Options & Structure Winner CBAN
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (100th %ile IV)
AUBN US Equity
AUBN
Institutional Equity
$24.50
-2.97% 1D
Market Cap $87.9M
1M Return -9.19%
1Y Return -10.89%
Forward P/E 9.2x
Unified AI Score
53.7 / 100 HOLD
Tech 58.0 Fund 57.0 Flow 50.0 Mom 58.9
CBAN NYSE
Colony Bankcorp Inc.
State Commercial Banks
$19.22
-1.99% 1D
Market Cap $535.3M
1M Return -5.09%
1Y Return +18.94%
Forward P/E 8.0x
Unified AI Score
44.5 / 100 HOLD
Tech 30.0 Fund 46.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AUBN -10.89% CBAN +18.94% Spread: +17.91 pp (CBAN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AUBN TTM Op. Margin: 33.5% CBAN TTM Op. Margin: 33.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AUBN vs CBAN. Trailing 12-month operating profitability (AUBN 33.5% vs CBAN 33.4%) and valuation multiples (AUBN 9.2x vs CBAN 8.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AUBN (3) vs CBAN (6)
Institutional Metric AUBN CBAN Criterion Row Winner
Market Capitalization Scale $87.9M $535.3M Larger Scale CBAN
Trailing P/E Ratio Valuation 10.1x 10.8x Lower Multiple AUBN
Forward P/E Ratio Valuation 9.2x 8.0x Lower Multiple CBAN
Revenue Growth (YoY) Growth +4.4% +26.0% Higher Growth CBAN
Operating Margin (TTM) Profitability 33.5% 33.4% Higher Margin Tie
Net Profit Margin Profitability 25.2% 24.3% Higher Margin AUBN
Return on Equity (ROE) Capital Efficiency 9.7% 10.8% Higher ROE CBAN
52-Week Range Position Momentum 44% ($21โ€“$29) 49% ($16โ€“$22) Stronger Trend CBAN
Beta / 30D Volatility Risk Regime 0.06ฮฒ ยท 38% Vol 0.39ฮฒ ยท 19% Vol Lower Realized Risk CBAN
Unified Institutional Score Composite Signal 53.7 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite AUBN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AUBN vs CBAN Buy Guide
AUBN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AUBN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CBAN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live CBAN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AUBN nor CBAN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.